Specials Laboratory to supply clinical trials service to UK hospitals
New service aims to meet the product manufacturing needs of NHS-based clinical trials
The Specials Laboratory, based in Northumberland, is to specialise in the supply of non-sterile products for use in small-scale clinical studies direct to hospitals after the specialist firm was licensed for the manufacture of investigational medicinal products (IMPs).
The new IMP service will assist clinical trial pharmacists and technicians, university medical schools and research doctors.
Operating from three MHRA-approved facilities, the company complies with current Good Manufacturing Practice (cGMP) and provides in-house Quality Person (QP) release, which will ensure products delivered to hospitals will be made to the highest possible quality standards.
‘Our quality-led manufacturing heritage allows us to produce virtually any non-sterile dosage form,’ said Robert Sludden, Quality and Technical Services Manager at The Specials Laboratory.
‘The company is also able to offer customers an experienced technical team that includes several pharmacists, senior pharmacy technicians and QPs – many with an extensive NHS background.’
With more hospitals opting to subcontract their IMP manufacturing needs, The Specials Laboratory is looking to build relationships with relevant NHS departments by offering to be their outsourced manufacturing partner supplying products for smaller clinical trials.
‘Hospital departments will be able to source a wide range of products from The Specials Laboratory for their IMP manufacturing requirements, including oral liquids, capsules, sachets, ointments, creams, ear and nasal drops, enema solutions, suppositories and pessaries,' added Sludden.
Set-up over a decade ago, The Specials Laboratory employs around 130 people and is a leading UK manufacturer of unlicensed medicines, which are bespoke for individual patients and supplied to community and hospital pharmacists and doctors.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Marketing
Guardtech Group welcome new ‘cleanroom chameleon’ mascot into the mix to celebrate company’s role as enablers of change
Cammi the Chameleon will be appearing across the East Anglian cleanroom construction specialists’ marketing throughout 2026 to represent Guardtech’s aim to support groundbreaking developments in Life Sciences and beyond
Drug Delivery
SCHOTT Pharma and SHL Medical pre-validate polymer cartridge platform for large-volume autoinjectors
SCHOTT Pharma has pre-validated its ISO-standardised TOPPAC polymer cartridge for compatibility with SHL Medical’s large-volume Maggie autoinjector platform. The collaboration delivers a de-risked, ready-to-use solution for the safe at-home administration of large-volume therapies
Sustainability
BioDuro sites recognised with EcoVadis Gold and Silver sustainability certifications
Three of the CDMO's Chinese sites have been recognised for outstanding sustainability performance, highlighting BioDuro’s commitment to sustainability and its ongoing efforts to embed environmental and social responsibility into its business operations
Manufacturing
IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility
Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
Manufacturing
Cellistic launches three new iPSC-based GMP platforms to advance immuno-oncology and regenerative therapies
The three new iPSC-derived GMP manufacturing platforms, Echo-T, Echo-Cardio and Echo-Endothelial, expand the company’s Echo portfolio and are designed to improve scalability and manufacturability across immuno-oncology and regenerative medicine programmes